28164568|t|Methylation Analysis of BRCA1 and APC in Breast Cancer and It's Relationship to Clinicopathological Features
28164568|a|Promoter methylation of tumor suppressor genes is an important epigenetic alteration that occurs in the primary stages of human tumors, including breast cancer. Identification of methylated genes and their relationship to clinical features can contribute to the prognosis and early detection of tumors. In this study, we explored the methylation status of APC and BRCA1 genes and their relationship to clinical factors in breast cancer patients. BRCA1 and APC promoter methylation was examined by methylation - specific multiplex ligation-dependent probe amplification (MS-MLPA) assay in formalin-fixed paraffin embedded (FFPE) breast tissue from 75 patients. APC promoter methylation was detected in 30.67% breast cancer tissues and BRCA1 was methylated in 9.33% of breast tumors. Methylation of APC was associated with low histological grade (p = 0.006) and methylation of BRCA1 was related with lymph node metastasis (p = 0.017). These findings suggest that the methylation status of APC and BRCA1 can be a predictive marker for early detection and better management of breast cancer patients.
28164568	0	20	Methylation Analysis	T063	C1880239
28164568	24	29	BRCA1	T028	C0376571
28164568	34	37	APC	T028	C0162832
28164568	41	54	Breast Cancer	T191	C0006142
28164568	64	76	Relationship	T080	C0439849
28164568	80	99	Clinicopathological	T169	C1521733
28164568	100	108	Features	T080	C2348519
28164568	109	129	Promoter methylation	T044	C0376452
28164568	133	155	tumor suppressor genes	T028	C0079427
28164568	172	193	epigenetic alteration	T045	C1516924
28164568	213	220	primary	T080	C0205225
28164568	221	227	stages	T079	C1306673
28164568	231	236	human	T016	C0086418
28164568	237	243	tumors	T191	C0027651
28164568	255	268	breast cancer	T191	C0006142
28164568	288	304	methylated genes	T028	C0017337
28164568	315	327	relationship	T080	C0439849
28164568	331	339	clinical	T080	C0205210
28164568	340	348	features	T080	C2348519
28164568	371	380	prognosis	T058	C0033325
28164568	385	400	early detection	T060	C0596473
28164568	404	410	tumors	T191	C0027651
28164568	420	425	study	T062	C2603343
28164568	443	454	methylation	T044	C0376452
28164568	455	461	status	T080	C0449438
28164568	465	468	APC	T028	C0162832
28164568	473	484	BRCA1 genes	T028	C0376571
28164568	495	507	relationship	T080	C0439849
28164568	511	519	clinical	T080	C0205210
28164568	520	527	factors	T169	C1521761
28164568	531	544	breast cancer	T191	C0006142
28164568	545	553	patients	T101	C0030705
28164568	555	560	BRCA1	T028	C0376571
28164568	565	568	APC	T028	C0162832
28164568	569	589	promoter methylation	T044	C0376452
28164568	606	617	methylation	T044	C0025723
28164568	620	677	specific multiplex ligation-dependent probe amplification	T063	C3494189
28164568	679	686	MS-MLPA	T063	C3494189
28164568	688	693	assay	T059	C1510438
28164568	697	750	formalin-fixed paraffin embedded (FFPE) breast tissue	T024	C2711483
28164568	759	767	patients	T101	C0030705
28164568	769	772	APC	T028	C0162832
28164568	773	793	promoter methylation	T044	C0376452
28164568	798	806	detected	T033	C0442726
28164568	817	830	breast cancer	T191	C0006142
28164568	831	838	tissues	T024	C0040300
28164568	843	848	BRCA1	T028	C0376571
28164568	853	863	methylated	T044	C0376452
28164568	876	889	breast tumors	T191	C1458155
28164568	891	902	Methylation	T044	C0376452
28164568	906	909	APC	T028	C0162832
28164568	914	929	associated with	T080	C0332281
28164568	934	952	histological grade	T185	C0456201
28164568	969	980	methylation	T044	C0376452
28164568	984	989	BRCA1	T028	C0376571
28164568	1007	1017	lymph node	T023	C0024204
28164568	1018	1028	metastasis	T046	C4255448
28164568	1048	1056	findings	T033	C0243095
28164568	1074	1085	methylation	T044	C0376452
28164568	1086	1092	status	T080	C0449438
28164568	1096	1099	APC	T028	C0162832
28164568	1104	1109	BRCA1	T028	C0376571
28164568	1119	1136	predictive marker	T201	C0005516
28164568	1141	1156	early detection	T060	C0596473
28164568	1168	1178	management	T058	C0376636
28164568	1182	1195	breast cancer	T191	C0006142
28164568	1196	1204	patients	T101	C0030705